• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用固定时长与所有可用协变量评估期来量化偏差减少。

Quantifying bias reduction with fixed-duration versus all-available covariate assessment periods.

机构信息

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Pharmacoepidemiol Drug Saf. 2019 May;28(5):665-670. doi: 10.1002/pds.4729. Epub 2019 Feb 20.

DOI:10.1002/pds.4729
PMID:30786103
Abstract

PURPOSE

Implementing a cohort study in longitudinal healthcare databases requires looking back over some covariate assessment period (CAP) preceding cohort entry to measure confounders. We used simulations to compare fixed-duration versus all-available CAPs for confounder adjustment in the presence of differences in available baseline time between exposure groups.

METHODS

We simulated cohorts of 10 000 patients with binary variables for a single confounder, exposure, and outcome. Baseline time was simulated based on the observed distribution in a claims-based comparison of statin users versus nonusers. We compared bias after measuring confounders using fixed-duration and all-available CAPs, both when exposure groups had similar and discrepant amounts of available baseline time.

RESULTS

When the comparison groups had similar amounts of baseline time, an all-available CAP was less biased than a fixed-duration CAP. When baseline time differed between comparison groups, the preferable CAP approach depended on the direction of confounding and which exposure group had higher covariate sensitivity. These findings were consistent in direction across sensitivity analyses.

CONCLUSION

In certain settings of differential available baseline time between exposure groups, the all-available CAP was more biased than the fixed-duration CAP. The relative directions and strengths of confounding and misclassification biases are an important consideration when choosing between a fixed-duration or all-available CAP, but they are often unknown. Therefore, we recommend comparing the amount of available baseline time between exposure groups. When there is a large discrepancy, despite appropriate design choices, we recommend a fixed-duration approach to avoid potential increases in bias because of differential data availability.

摘要

目的

在纵向医疗保健数据库中实施队列研究需要回顾队列入组前的一段时间(CAP),以测量混杂因素。我们使用模拟比较了在暴露组之间可用基线时间存在差异的情况下,固定时长和所有可用 CAP 用于混杂因素调整的效果。

方法

我们模拟了 10000 名患者的队列,其中包含一个混杂因素、暴露和结局的二分类变量。根据他汀类药物使用者与非使用者的索赔比较中观察到的分布,模拟了基线时间。我们比较了使用固定时长和所有可用 CAP 测量混杂因素后的偏倚,同时比较了暴露组具有相似和不同可用基线时间的情况。

结果

当比较组具有相似的基线时间时,所有可用 CAP 比固定时长 CAP 的偏倚更小。当比较组的基线时间存在差异时,首选的 CAP 方法取决于混杂的方向以及哪个暴露组具有更高的协变量敏感性。这些发现在敏感性分析中具有一致的方向。

结论

在暴露组之间可用基线时间存在差异的某些情况下,所有可用 CAP 比固定时长 CAP 的偏倚更大。混杂和分类错误偏倚的相对方向和强度是在固定时长或所有可用 CAP 之间选择时的重要考虑因素,但通常是未知的。因此,我们建议比较暴露组之间的可用基线时间。当存在很大差异时,尽管进行了适当的设计选择,我们建议采用固定时长方法,以避免因数据可用性差异而导致潜在的偏倚增加。

相似文献

1
Quantifying bias reduction with fixed-duration versus all-available covariate assessment periods.用固定时长与所有可用协变量评估期来量化偏差减少。
Pharmacoepidemiol Drug Saf. 2019 May;28(5):665-670. doi: 10.1002/pds.4729. Epub 2019 Feb 20.
2
Effects of expanding the look-back period to all available data in the assessment of covariates.在协变量评估中扩大回顾期至所有可用数据的影响。
Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):890-899. doi: 10.1002/pds.4210. Epub 2017 Apr 11.
3
Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates.使用所有可用协变量信息进行估计与使用固定回溯窗口进行二分类协变量的估计。
Pharmacoepidemiol Drug Saf. 2013 May;22(5):542-50. doi: 10.1002/pds.3434. Epub 2013 Mar 22.
4
An empirical assessment of immeasurable time bias in the setting of nested case-control studies: Statins and all-cause mortality among patients with heart failure.嵌套病例对照研究中无法衡量的时间偏差的实证评估:心力衰竭患者中他汀类药物与全因死亡率。
Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1318-1327. doi: 10.1002/pds.4888. Epub 2019 Aug 20.
5
Controlling confounding of treatment effects in administrative data in the presence of time-varying baseline confounders.在存在随时间变化的基线混杂因素的情况下,控制行政数据中治疗效果的混杂因素。
Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):269-77. doi: 10.1002/pds.3922. Epub 2015 Nov 26.
6
Inflation of type I error rates due to differential misclassification in EHR-derived outcomes: Empirical illustration using breast cancer recurrence.由于电子病历衍生结局的差异误分类导致 I 类错误率膨胀:基于乳腺癌复发的实证说明。
Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):264-268. doi: 10.1002/pds.4680. Epub 2018 Oct 30.
7
A comparison of estimators from self-controlled case series, case-crossover design, and sequence symmetry analysis for pharmacoepidemiological studies.自对照病例系列研究、病例交叉设计和序列对称分析方法在药物流行病学研究中估计量的比较。
BMC Med Res Methodol. 2018 Jan 8;18(1):4. doi: 10.1186/s12874-017-0457-7.
8
An application of propensity score matching using claims data.一项使用理赔数据进行倾向得分匹配的应用。
Pharmacoepidemiol Drug Saf. 2005 Jul;14(7):465-76. doi: 10.1002/pds.1062.
9
Classifying medical histories in US Medicare beneficiaries using fixed vs all-available look-back approaches.使用固定与全可回溯方法对美国医疗保险受益人进行病历分类。
Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):771-780. doi: 10.1002/pds.4435. Epub 2018 Apr 14.
10
Limited impact of drug exposure misclassification from non-benefit thiazolidinedione drug use on mortality and hospitalizations from Saskatchewan, Canada: a cohort study.加拿大萨斯喀彻温省非受益性噻唑烷二酮类药物使用导致的药物暴露错误分类对死亡率和住院率的影响有限:一项队列研究
Clin Ther. 2015 Mar 1;37(3):629-42. doi: 10.1016/j.clinthera.2014.12.014. Epub 2015 Jan 14.

引用本文的文献

1
Evaluating methods to define place of residence in Canadian administrative data and the impact on observed associations with all-cause mortality in type 2 diabetes.评估加拿大行政数据中定义居住地的方法及其对观察到的2型糖尿病全因死亡率关联的影响。
BMC Med Res Methodol. 2025 Mar 18;25(1):76. doi: 10.1186/s12874-025-02531-3.
2
Impact of observability period on the classification of COPD diagnosis timing among Medicare beneficiaries with lung cancer.可观察期对医疗保险受益的肺癌患者慢性阻塞性肺疾病(COPD)诊断时间分类的影响
PLOS Digit Health. 2024 Oct 22;3(10):e0000633. doi: 10.1371/journal.pdig.0000633. eCollection 2024 Oct.
3
Abuse-deterrent formulations and opioid-related harms in North Carolina, 2010-2018.
2010 - 2018年北卡罗来纳州的抗滥用制剂与阿片类药物相关危害
Am J Epidemiol. 2025 Mar 4;194(3):680-690. doi: 10.1093/aje/kwae252.
4
Risk factors for hyponatremia associated with desmopressin use.与使用去氨加压素相关的低钠血症的危险因素。
Transl Androl Urol. 2024 Jun 30;13(6):923-929. doi: 10.21037/tau-24-4. Epub 2024 Jun 18.
5
Noninterventional studies in the COVID-19 era: methodological considerations for study design and analysis.新冠疫情时代的非干预性研究:研究设计和分析的方法学考虑。
J Clin Epidemiol. 2023 Jan;153:91-101. doi: 10.1016/j.jclinepi.2022.11.011. Epub 2022 Nov 17.
6
A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates.一项针对 2008 年至 2018 年挪威心力衰竭的全国性注册研究:回顾期的差异影响发病率估计。
BMC Cardiovasc Disord. 2022 Mar 5;22(1):88. doi: 10.1186/s12872-022-02522-y.
7
Characterizing Bias Due to Differential Exposure Ascertainment in Electronic Health Record Data.电子健康记录数据中因差异暴露确定导致的偏倚特征分析
Health Serv Outcomes Res Methodol. 2021 Sep;21(3):309-323. doi: 10.1007/s10742-020-00235-3. Epub 2021 Jan 4.
8
Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis.肿瘤坏死因子抑制剂和甲氨蝶呤对炎症性关节炎患者糖尿病的影响。
BMC Rheumatol. 2020 Sep 2;4:39. doi: 10.1186/s41927-020-00138-3. eCollection 2020.
9
Desmopressin and the risk of hyponatremia: A population-based cohort study.去氨加压素与低钠血症风险:基于人群的队列研究。
PLoS Med. 2019 Oct 21;16(10):e1002930. doi: 10.1371/journal.pmed.1002930. eCollection 2019 Oct.
10
Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients.降尿酸药物对痛风患者慢性肾脏病进展和恢复的影响。
Arthritis Res Ther. 2019 Sep 18;21(1):210. doi: 10.1186/s13075-019-1993-9.